Reproducibility of the six-minute walking test in chronic heart failure patients

This publication has 12 references indexed in Scilit:

• Randomised, double-blind, placebo-controlled trial of human recombinant growth hormone in patients with chronic heart failure due to dilated cardiomyopathy
  The Lancet, 1998
• Rationale, background, and design of the randomized angiotensin receptor antagonist—Angiotensin-converting enzyme inhibitor study (RAAS)
  The American Journal of Cardiology, 1996
• The Six-Minute Walk Test Predicts Peak Oxygen Uptake and Survival in Patients With Advanced Heart Failure
  Chest, 1996
• The Effect of Carvedilol on Morbidity and Mortality in Patients with Chronic Heart Failure
  New England Journal of Medicine, 1996
• Using exercise endpoints in heart failure trials: design considerations
  European Heart Journal, 1996
• Prediction of Mortality and Morbidity With a 6-Minute Walk Test in Patients With Left Ventricular Dysfunction
  JAMA, 1993
• Withdrawal of Digoxin from Patients with Chronic Heart Failure Treated with Angiotensin-Converting-Enzyme Inhibitors
  New England Journal of Medicine, 1993
• Measuring measuring errors
  Statistics in Medicine, 1989
• Six minute walking test for assessing exercise capacity in chronic heart failure.
  BMJ, 1986
• Effect of encouragement on walking test performance.
  Thorax, 1984